Real, reported in the trials, and in almost every case temporary. The cause is the weight loss rather than the molecule — which is also why protein is the lever that matters.
~3%Alopecia in the Wegovy trials, against about 1% on placebo
3–4 moWhen shedding usually starts after loss accelerates
3–6 moTypical time to resolve once the trigger settles
DiffuseThe pattern. Patchy loss is a different diagnosis
Key takeaways
Hair shedding on a GLP-1 is real, reported in the trials, and in almost all cases temporary.
Alopecia appeared in the Wegovy weight-management trials at roughly 3% against about 1% on placebo. European labelling classes it as a common side effect.
The mechanism is almost certainly telogen effluvium — the standard response to rapid weight loss and reduced intake, not the drug attacking follicles.
It typically begins two to four months after the weight loss accelerates, and usually resolves within three to six months.
Protein and micronutrient intake are the levers that matter, and both are easy to lose when appetite is suppressed.
Mostly not directly. The best explanation is telogen effluvium, the shedding pattern
that follows any large, rapid weight loss.
Hair grows in cycles. A physiological stress — rapid weight loss, a sharp drop in calorie and
protein intake, illness, surgery, childbirth — can push an unusually large share of follicles
from the growing phase into the resting phase at once. Those hairs then shed together, two to
four months later, which is why the shedding seems to arrive long after the thing that caused it.
People who lose the same amount of weight by other means report the same thing. That is the
strongest clue that this is a weight-loss effect rather than a semaglutide effect. Reduced intake
of iron, zinc, vitamin D and protein — all easy to under-eat on a suppressed appetite — are
recognised triggers in their own right.
What the trials reported
It appears in the labelling, at a low but real rate.
Alopecia as reported in semaglutide weight-management trials and labelling.
Reported
Wegovy weight-management trials
Alopecia in roughly 3% of adults, against about 1% on placebo
European labelling
Classed as a common side effect — at least 1 in 100
Ozempic prescribing information
Not listed
The Ozempic-versus-Wegovy difference in that table is worth reading carefully. It does not
mean the diabetes product is safer for hair. It means the weight-management trials produced far
more weight loss, and weight loss is the thing driving the shedding.
The timeline
Typical telogen effluvium pattern during rapid weight loss.
When
What happens
Months 1–2
Nothing visible. Weight loss is fastest here.
Months 3–4
Shedding starts — more hair in the brush, in the shower, on the pillow.
Months 4–6
Usually the peak. Diffuse thinning rather than bald patches.
Months 6–9
Shedding slows as weight loss slows. Regrowth begins.
Two features distinguish this from other hair loss: it is diffuse, spread across the
scalp rather than in patches or at the hairline, and it is self-limiting. Patchy loss,
or loss confined to the crown or temples, is a different problem and worth having looked at.
What actually helps
Hit a protein target. Hair is protein, and protein is the first thing to fall on a
suppressed appetite. The protein calculator
gives you a daily gram number rather than a vague intention.
Get iron, zinc and vitamin D checked if shedding is significant. All three are
recognised triggers and all three are easy to under-eat when you are eating much less overall.
Ask before supplementing — iron in particular is not harmless taken unnecessarily.
Do not crash the losing rate further. The faster the loss, the stronger the trigger.
If shedding is distressing, a slower rate is a legitimate thing to discuss.
Wait. Genuinely. Telogen effluvium resolves on its own in most cases once the
trigger settles, and most interventions sold for it are treating a condition that was going to
improve anyway.
When to get it looked at
Diffuse shedding that started a few months into significant weight loss and is
slowing is the expected pattern. These are not:
Patchy loss, or a receding hairline or thinning crown — a different diagnosis.
Shedding still worsening past nine months.
Hair loss with fatigue, cold intolerance or other systemic symptoms — thyroid function
is worth checking.
Scalp itching, scaling, redness or pain.
Common questions
Does Ozempic or Wegovy cause hair loss?
Alopecia was reported in the Wegovy weight-management trials in roughly 3% of adults against about 1% on placebo, and European labelling classes it as a common side effect. The mechanism is thought to be telogen effluvium from rapid weight loss and reduced intake rather than a direct effect on follicles.
Is GLP-1 hair loss permanent?
In most cases no. Telogen effluvium is self-limiting and typically resolves within three to six months once the trigger settles, with regrowth following.
When does the shedding start?
Usually two to four months after weight loss accelerates, because shed hairs were pushed into the resting phase months earlier. That delay is why it seems disconnected from the cause.
How do I stop hair loss on a GLP-1?
Meet a protein target, have iron, zinc and vitamin D checked if shedding is significant, and avoid pushing the rate of weight loss faster. Ask before supplementing rather than self-prescribing.
Should I stop the medication over hair loss?
That is a prescriber conversation, and worth having before acting. The shedding is usually temporary while the reasons you started are usually not. A slower rate of loss may address it without stopping.
Sources
Every figure on this page traces to one of these. Regulatory documents and
peer-reviewed primary research only — see our editorial policy
for what we accept as a source.
Alopecia and Semaglutide: Connecting the Dots for Patient Safety. PubMed Central. View source
WEGOVY (semaglutide) injection, US prescribing information. FDA, 2025. View source
Wilding JPH et al. Impact of Semaglutide on Body Composition in Adults With Overweight or Obesity: Exploratory Analysis of the STEP 1 Study. Journal of the Endocrine Society, 2021. View source
GLP-1 Agonists: What They Are, How They Work & Side Effects. Cleveland Clinic. View source
Protein is the lever. Track it.
The first thing to fall on a suppressed appetite, and the one that protects hair and lean tissue. GLPme keeps it on the same timeline as everything else. Core tracking is free.